Jennifer Peppe - 16 Aug 2022 Form 4 Insider Report for Imago BioSciences, Inc.

Role
Global Head, Clinical Operations
Signature
/s/ Hugh Rienhoff, as Attorney-in-fact for Jennifer Peppe
Issuer symbol
N/A
Transactions as of
16 Aug 2022
Net transactions value
-$108,147
Form type
4
Filing time
17 Aug 2022, 17:05:19 UTC
Previous filing
16 Aug 2022
Next filing
14 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGO Common Stock Options Exercise $16,133 +6,402 +4.3% $2.52* 155,211 16 Aug 2022 Direct F1
transaction IMGO Common Stock Sale $124,280 -6,402 -4.1% $19.41 148,809 16 Aug 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Stock Option (Right to Buy) Options Exercise $0 -6,402 -9.9% $0.000000 58,551 16 Aug 2022 Common Stock 6,402 $2.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The transaction was executed in multiple trades in prices ranging from $19.40 to $19.50, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Remarks:

Global Head, Clinical Operations